Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (351)	8/22/2001 2:06:57 PM
From: tuck	Read Replies (1) \| Respond to of 1005

My mistake that KOSN spike was not circumpachydermal, it was the recurring phenomenom of a MM going after a big low ball block. We need to put alerts on all these stocks to really catch this stuff: siliconinvestor.com At least, that's my take on the action. Differing opinions welcome. The daily makes me wonder if KOSN will retest its lows. siliconinvestor.com But isn't this the price at which that insider block buy was made? Anyhow, watching closely, and ready to pounce one more time. Edit: Pretty good volume in RIGL, and sorely tempted to buy more CALP. For now, BLUE HP will try 500 shares at $12.25. Anyone have an opinion as to how much per share research premium was added to RIGL when Novartis recently expanded their collaboration with them? I'm thinking that expecting to get below high $4s might be unrealistic, and that we are near a good entry point, as I thought when I first bought it for BLUE HP. Unless restrained, I will pick another 500 of RIGL at $4.85. Cheers, Tuck